Neurological Disorder Diagnostics Market to 2025 - Global Analysis and Forecasts ByTechnology (Imaging, and In Vitro Diagnostics), Disease Indication (Genetic Neurological Disorders, Immunological Neurological Disorders, Paraneoplastic Syndrome, Paraproteinemic Neuropathies, and Others) End User (Hospitals & Clinics, Diagnostic Centers, and Ambulatory Care Centers) and Geography
Report Code: TIPHE100001432 No. of Pages: 150 Category: Biotechnology Status: Upcoming
Diagnostic tests are the vital tools that helps to rule out or confirm the presence of neurological disorders among individuals facing specific symptoms. The advances in brain monitoring leads to live visualization of brain interior and live brain functions. This helps the neurologists to diagnose neurological diseases with accuracy. The diagnosis of neurological disorders is majorly performed by using two technologies such as imaging and in vitro diagnostics.
The growth of global neurological disorder diagnostics market is expected to be driven by factors such as increasing prevalence of cerebral and neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis among others, rapid growth in the geriatric population across the globe. However, the high costs of the imaging devices are expected to hinder the growth of this market. On the other hand, the potential ability and rising adoption of biomarkers to conduct diagnosis of various diseases is one of the most prevalent trend in the neurological disorder diagnostics market.
The "Global Neurological Disorder Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global neurological disorder diagnostics market with detailed market segmentation by technology, disease indication, end user and geography. The global neurological disorder diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global neurological disorder diagnostics market is segmented on the basis of technology, disease indication, and end user. On the basis of technology, the global neurological disorder diagnostics market is segmented into imaging and in vitro diagnostics. Based on disease indication, the market is segmented into genetic neurological diseases, immunological neurological diseases, parenoplastic syndrome, paraproteinemic neuropathies, and others. On the basis of end user, the global neurological disorder diagnostics market is segmented in to hospitals & clinics, diagnostic centers, and ambulatory care centers.
The neurological disorder diagnostics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurological disorder diagnostics market based on technology, disease indication and end user. It also provides market size and forecast till 2025 for overall neurological disorder diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global neurological disorder diagnostics market. This is primarily attributed to the high prevalence of brain related disorders among the geriatric population and increasing number of innovative product launches through technological advancement in this region. On the other hand, Asia Pacific is expected to witness significant growth during the forecast period owing to the development of novel diagnostic products at affordable costs in this region.
The neurological disorder diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The neurological disorder diagnostics market report also includes the profiles of leading neurological disorder diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global neurological disorder diagnostics market include Siemens, Koninklijke Philips N.V., General Electric, Esaote SpA, NeuroLogica Corp., Masimo, York Instruments Ltd, Canon Medical Systems Corporation, Natus Medical Incorporated, and Ectron among others.
The growth of global neurological disorder diagnostics market is expected to be driven by factors such as increasing prevalence of cerebral and neurological disorders such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis among others, rapid growth in the geriatric population across the globe. However, the high costs of the imaging devices are expected to hinder the growth of this market. On the other hand, the potential ability and rising adoption of biomarkers to conduct diagnosis of various diseases is one of the most prevalent trend in the neurological disorder diagnostics market.
The "Global Neurological Disorder Diagnostics Market Analysis to 2025" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global neurological disorder diagnostics market with detailed market segmentation by technology, disease indication, end user and geography. The global neurological disorder diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global neurological disorder diagnostics market is segmented on the basis of technology, disease indication, and end user. On the basis of technology, the global neurological disorder diagnostics market is segmented into imaging and in vitro diagnostics. Based on disease indication, the market is segmented into genetic neurological diseases, immunological neurological diseases, parenoplastic syndrome, paraproteinemic neuropathies, and others. On the basis of end user, the global neurological disorder diagnostics market is segmented in to hospitals & clinics, diagnostic centers, and ambulatory care centers.
The neurological disorder diagnostics market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neurological disorder diagnostics market based on technology, disease indication and end user. It also provides market size and forecast till 2025 for overall neurological disorder diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds a dominant position in the global neurological disorder diagnostics market. This is primarily attributed to the high prevalence of brain related disorders among the geriatric population and increasing number of innovative product launches through technological advancement in this region. On the other hand, Asia Pacific is expected to witness significant growth during the forecast period owing to the development of novel diagnostic products at affordable costs in this region.
The neurological disorder diagnostics market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The neurological disorder diagnostics market report also includes the profiles of leading neurological disorder diagnostics manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key developments in past five years. Some of the key players operating the global neurological disorder diagnostics market include Siemens, Koninklijke Philips N.V., General Electric, Esaote SpA, NeuroLogica Corp., Masimo, York Instruments Ltd, Canon Medical Systems Corporation, Natus Medical Incorporated, and Ectron among others.
1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neurological Disorder Diagnostics Market - By Technology
3.2.2. Neurological Disorder Diagnostics Market - By Disease Indication
3.2.3. Neurological Disorder Diagnostics Market - By End User
3.2.4. Neurological Disorder Diagnostics Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
5.6. CLINICAL TRIAL ANALYSIS
6. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. IMAGING MARKET
6.3.1. Overview
6.3.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Computed Tomography Market
6.3.3.1. Overview
6.3.3.2. Computed Tomography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Magnetic Resonance Imaging Market
6.3.4.1. Overview
6.3.4.2. Magnetic Resonance Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Nuclear Medicine Imaging
6.3.5.1. Overview
6.3.5.2. Nuclear Medicine Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Positron Emission Tomography Market
6.3.6.1. Overview
6.3.6.2. Positron Emission Tomography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.7. Single-Photon Emission Computed Tomography (SPECT) Market
6.3.7.1. Overview
6.3.7.2. Single-Photon Emission Computed Tomography (SPECT) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.8. Near Infrared Spectroscopic Imaging Market
6.3.8.1. Overview
6.3.8.2. Near Infrared Spectroscopic Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.9. Electroencephalography Market
6.3.9.1. Overview
6.3.9.2. Electroencephalography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.10. Magnetoencephalography Market
6.3.10.1. Overview
6.3.10.2. Magnetoencephalography Market Revenue Forecasts and Analysis (US$ Mn)
6.4. IN VITRO DIAGNOSTICS MARKET
6.4.1. Overview
6.4.2. In Vitro Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Biomarkers Market
6.4.3.1. Overview
6.4.3.2. Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Biopsy Market
6.4.4.1. Overview
6.4.4.2. Biopsy Market Revenue Forecasts and Analysis (US$ Mn)
6.4.5. Others Market
6.4.5.1. Overview
6.4.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. GENETIC NEUROLOGICAL DISORDERS MARKET
7.3.1. Overview
7.3.2. Genetic Neurological Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.4. IMMUNOLOGICAL NEUROLOGICAL DISORDERS MARKET
7.4.1. Overview
7.4.2. Immunological Neurological Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.5. PARENTOPLASTIC SYNDROME MARKET
7.5.1. Overview
7.5.2. Parentoplastic Syndrome Market Revenue Forecasts and Analysis (US$ Mn)
7.6. PARAPROTEINIMIC NEUROPATHIES MARKET
7.6.1. Overview
7.6.2. Paraproteinimic Neuropathies Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHERS MARKET
7.7.1. Overview
7.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. DIAGNOSTIC CENTERS MARKET
8.4.1. Overview
8.4.2. Diagnostic Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. AMBULATORY CARE CENTERS MARKET
8.5.1. Overview
8.5.2. Ambulatory Care Centers Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
9.2. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. North America In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
9.5. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. US Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. US In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.7.3. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Canada Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. Canada In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.8.3. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.9.1.1. Mexico Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.9.1.2. Mexico In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.9.2. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.9.3. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
10.2. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Europe In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
10.5. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. UK Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. UK In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.7.3. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. Germany Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. Germany In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.8.3. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.1.1. France Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.9.1.2. France In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.9.2. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.9.3. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.2. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.2.1. Asia Pacific Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.2.2. Asia Pacific In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
11.4. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.1.1. Japan Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. Japan In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.6.3. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. China Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.1.2. China In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.7.3. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. India Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.1.2. India In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.8.3. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.2. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.2.1. Middle East and Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.2.2. Middle East and Africa In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.3. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
12.4. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.1.1. South Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.1.2. South Africa In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.6.3. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. Saudi Arabia Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.7.1.2. Saudi Arabia In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.7.2. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.7.3. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. UAE Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.8.1.2. UAE In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.8.2. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.8.3. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.2. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.2.1. South and Central America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.2.2. South and Central America In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.3. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.6.1.1. Brazil Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.6.1.2. Brazil In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.6.2. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.6.3. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
15.1. SIEMENS
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. KONINKLIJKE PHILIPS N.V.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. GENERAL ELECTRIC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. ESAOTE SPA
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. NEUROLOGICA CORP.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. MASIMO
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. YORK INSTRUMENTS LTD.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. CANON MEDICAL SYSTEMS CORPORATION
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. NATUS MEDICAL INCORPORATED
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. ECTRON
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
2. KEY TAKEAWAYS
3. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neurological Disorder Diagnostics Market - By Technology
3.2.2. Neurological Disorder Diagnostics Market - By Disease Indication
3.2.3. Neurological Disorder Diagnostics Market - By End User
3.2.4. Neurological Disorder Diagnostics Market - By Region
3.2.4.1. By Country
3.3. PEST ANALYSIS
3.3.1. North America - PEST Analysis
3.3.2. Europe - PEST Analysis
3.3.3. Asia Pacific - PEST Analysis
3.3.4. Middle East and Africa - PEST Analysis
3.3.5. South and Central America- PEST Analysis
4. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. FUTURE TRENDS
4.5. IMPACT ANALYSIS
5. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET - GLOBAL ANALYSIS
5.1. GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
5.2. GLOBAL NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. MARKET POSITIONING/MARKET SHARE
5.4. PERFORMANCE OF KEY PLAYERS
5.5. EXPERT OPINIONS
5.6. CLINICAL TRIAL ANALYSIS
6. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY TECHNOLOGY
6.1. OVERVIEW
6.2. TECHNOLOGY MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. IMAGING MARKET
6.3.1. Overview
6.3.2. Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.3. Computed Tomography Market
6.3.3.1. Overview
6.3.3.2. Computed Tomography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.4. Magnetic Resonance Imaging Market
6.3.4.1. Overview
6.3.4.2. Magnetic Resonance Market Revenue Forecasts and Analysis (US$ Mn)
6.3.5. Nuclear Medicine Imaging
6.3.5.1. Overview
6.3.5.2. Nuclear Medicine Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.6. Positron Emission Tomography Market
6.3.6.1. Overview
6.3.6.2. Positron Emission Tomography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.7. Single-Photon Emission Computed Tomography (SPECT) Market
6.3.7.1. Overview
6.3.7.2. Single-Photon Emission Computed Tomography (SPECT) Market Revenue Forecasts and Analysis (US$ Mn)
6.3.8. Near Infrared Spectroscopic Imaging Market
6.3.8.1. Overview
6.3.8.2. Near Infrared Spectroscopic Imaging Market Revenue Forecasts and Analysis (US$ Mn)
6.3.9. Electroencephalography Market
6.3.9.1. Overview
6.3.9.2. Electroencephalography Market Revenue Forecasts and Analysis (US$ Mn)
6.3.10. Magnetoencephalography Market
6.3.10.1. Overview
6.3.10.2. Magnetoencephalography Market Revenue Forecasts and Analysis (US$ Mn)
6.4. IN VITRO DIAGNOSTICS MARKET
6.4.1. Overview
6.4.2. In Vitro Diagnostics Market Revenue Forecasts and Analysis (US$ Mn)
6.4.3. Biomarkers Market
6.4.3.1. Overview
6.4.3.2. Biomarkers Market Revenue Forecasts and Analysis (US$ Mn)
6.4.4. Biopsy Market
6.4.4.1. Overview
6.4.4.2. Biopsy Market Revenue Forecasts and Analysis (US$ Mn)
6.4.5. Others Market
6.4.5.1. Overview
6.4.5.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
7. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY DISEASE INDICATION
7.1. OVERVIEW
7.2. DISEASE INDICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. GENETIC NEUROLOGICAL DISORDERS MARKET
7.3.1. Overview
7.3.2. Genetic Neurological Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.4. IMMUNOLOGICAL NEUROLOGICAL DISORDERS MARKET
7.4.1. Overview
7.4.2. Immunological Neurological Disorders Market Revenue Forecasts and Analysis (US$ Mn)
7.5. PARENTOPLASTIC SYNDROME MARKET
7.5.1. Overview
7.5.2. Parentoplastic Syndrome Market Revenue Forecasts and Analysis (US$ Mn)
7.6. PARAPROTEINIMIC NEUROPATHIES MARKET
7.6.1. Overview
7.6.2. Paraproteinimic Neuropathies Market Revenue Forecasts and Analysis (US$ Mn)
7.7. OTHERS MARKET
7.7.1. Overview
7.7.2. Others Market Revenue Forecasts and Analysis (US$ Mn)
8. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - BY END USER
8.1. OVERVIEW
8.2. END USER MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
8.3. HOSPITALS & CLINICS MARKET
8.3.1. Overview
8.3.2. Hospitals & Clinics Market Revenue Forecasts and Analysis (US$ Mn)
8.4. DIAGNOSTIC CENTERS MARKET
8.4.1. Overview
8.4.2. Diagnostic Centers Market Revenue Forecasts and Analysis (US$ Mn)
8.5. AMBULATORY CARE CENTERS MARKET
8.5.1. Overview
8.5.2. Ambulatory Care Centers Market Revenue Forecasts and Analysis (US$ Mn)
9. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
9.1. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
9.2. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
9.3.1. North America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.3.2. North America In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.4. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
9.5. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
9.6. NORTH AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
9.7. US MARKET OVERVIEW
9.7.1. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.7.1.1. US Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.1.2. US In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.7.2. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.7.3. US Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.8. CANADA MARKET OVERVIEW
9.8.1. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.8.1.1. Canada Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.1.2. Canada In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.8.2. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.8.3. Canada Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
9.9. MEXICO MARKET OVERVIEW
9.9.1. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
9.9.1.1. Mexico Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.9.1.2. Mexico In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
9.9.2. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
9.9.3. Mexico Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
10.1. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET OVERVIEW
10.2. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
10.3.1. Europe Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.3.2. Europe In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.4. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
10.5. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
10.6. EUROPE NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
10.7. UK MARKET OVERVIEW
10.7.1. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.7.1.1. UK Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.1.2. UK In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.7.2. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.7.3. UK Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.8. GERMANY MARKET OVERVIEW
10.8.1. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.8.1.1. Germany Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.1.2. Germany In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.8.2. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.8.3. Germany Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
10.9. FRANCE MARKET OVERVIEW
10.9.1. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
10.9.1.1. France Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.9.1.2. France In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
10.9.2. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
10.9.3. France Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
11.1. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.2. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
11.2.1. Asia Pacific Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.2.2. Asia Pacific In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.3. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
11.4. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
11.5. ASIA PACIFIC NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
11.6. JAPAN MARKET OVERVIEW
11.6.1. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.6.1.1. Japan Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.1.2. Japan In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.6.2. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.6.3. Japan Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.7. CHINA MARKET OVERVIEW
11.7.1. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.7.1.1. China Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.1.2. China In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.7.2. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.7.3. China Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
11.8. INDIA MARKET OVERVIEW
11.8.1. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
11.8.1.1. India Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.1.2. India In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
11.8.2. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
11.8.3. India Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12. MIDDLE EAST AND AFRICA (MEA) NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
12.1. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.2. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
12.2.1. Middle East and Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.2.2. Middle East and Africa In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.3. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
12.4. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
12.5. MIDDLE EAST AND AFRICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
12.6. SOUTH AFRICA MARKET OVERVIEW
12.6.1. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.6.1.1. South Africa Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.1.2. South Africa In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.6.2. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.6.3. South Africa Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.7. SAUDI ARABIA MARKET OVERVIEW
12.7.1. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.7.1.1. Saudi Arabia Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.7.1.2. Saudi Arabia In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.7.2. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.7.3. Saudi Arabia Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
12.8. UAE MARKET OVERVIEW
12.8.1. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
12.8.1.1. UAE Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.8.1.2. UAE In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
12.8.2. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
12.8.3. UAE Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
13. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 - COUNTRY ANALYSIS
13.1. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
13.2. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY TECHNOLOGY (US$ MN)
13.2.1. South and Central America Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.2.2. South and Central America In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.3. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY DISEASE INDICATION (US$ MN)
13.4. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY END USER (US$ MN)
13.5. SOUTH AND CENTRAL AMERICA NEUROLOGICAL DISORDER DIAGNOSTICS MARKET REVENUE AND FORECASTS ANALYSIS - BY COUNTRY
13.6. BRAZIL MARKET OVERVIEW
13.6.1. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Technology (US$ Mn)
13.6.1.1. Brazil Imaging Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.6.1.2. Brazil In Vitro Diagnostics Market Revenue and Forecasts Analysis - By Type (US$ Mn)
13.6.2. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By Disease Indication (US$ Mn)
13.6.3. Brazil Neurological Disorder Diagnostics Market Revenue Forecasts and Analysis - By End User (US$ Mn)
14. INDUSTRY LANDSCAPE
14.1. ORGANIC GROWTH STRATEGIES
14.1.1. New Product Launches
14.1.2. Marketing & Promotional Activities
14.2. INORGANIC GROWTH STRATEGIES
14.2.1. Partnerships, Collaborations, and Joint Ventures
14.2.2. Mergers & Acquisitions
15. NEUROLOGICAL DISORDER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
15.1. SIEMENS
15.1.1. Key Facts
15.1.2. Business Description
15.1.3. Financial Overview
15.1.4. Product Portfolio
15.1.5. Product Pipeline
15.1.6. SWOT Analysis
15.1.7. Key Developments
15.2. KONINKLIJKE PHILIPS N.V.
15.2.1. Key Facts
15.2.2. Business Description
15.2.3. Financial Overview
15.2.4. Product Portfolio
15.2.5. Product Pipeline
15.2.6. SWOT Analysis
15.2.7. Key Developments
15.3. GENERAL ELECTRIC
15.3.1. Key Facts
15.3.2. Business Description
15.3.3. Financial Overview
15.3.4. Product Portfolio
15.3.5. Product Pipeline
15.3.6. SWOT Analysis
15.3.7. Key Developments
15.4. ESAOTE SPA
15.4.1. Key Facts
15.4.2. Business Description
15.4.3. Financial Overview
15.4.4. Product Portfolio
15.4.5. Product Pipeline
15.4.6. SWOT Analysis
15.4.7. Key Developments
15.5. NEUROLOGICA CORP.
15.5.1. Key Facts
15.5.2. Business Description
15.5.3. Financial Overview
15.5.4. Product Portfolio
15.5.5. Product Pipeline
15.5.6. SWOT Analysis
15.5.7. Key Developments
15.6. MASIMO
15.6.1. Key Facts
15.6.2. Business Description
15.6.3. Financial Overview
15.6.4. Product Portfolio
15.6.5. Product Pipeline
15.6.6. SWOT Analysis
15.6.7. Key Developments
15.7. YORK INSTRUMENTS LTD.
15.7.1. Key Facts
15.7.2. Business Description
15.7.3. Financial Overview
15.7.4. Product Portfolio
15.7.5. Product Pipeline
15.7.6. SWOT Analysis
15.7.7. Key Developments
15.8. CANON MEDICAL SYSTEMS CORPORATION
15.8.1. Key Facts
15.8.2. Business Description
15.8.3. Financial Overview
15.8.4. Product Portfolio
15.8.5. Product Pipeline
15.8.6. SWOT Analysis
15.8.7. Key Developments
15.9. NATUS MEDICAL INCORPORATED
15.9.1. Key Facts
15.9.2. Business Description
15.9.3. Financial Overview
15.9.4. Product Portfolio
15.9.5. Product Pipeline
15.9.6. SWOT Analysis
15.9.7. Key Developments
15.10. ECTRON
15.10.1. Key Facts
15.10.2. Business Description
15.10.3. Financial Overview
15.10.4. Product Portfolio
15.10.5. Product Pipeline
15.10.6. SWOT Analysis
15.10.7. Key Developments
16. APPENDIX
16.1. ABOUT THE INSIGHT PARTNERS
16.2. GLOSSARY OF TERMS
16.3. RESEARCH METHODOLOGY
The List of Companies
1 SIEMENS
2 Koninklijke Philips N.V.
3 GENERAL ELECTRIC
4 Esaote SpA
5 NeuroLogica Corp.
6 Masimo
7 YORK INSTRUMENTS, INC.
8 Canon Medical Systems Corporation
9 Natus Medical Incorporated
10 ECTRON
1 SIEMENS
2 Koninklijke Philips N.V.
3 GENERAL ELECTRIC
4 Esaote SpA
5 NeuroLogica Corp.
6 Masimo
7 YORK INSTRUMENTS, INC.
8 Canon Medical Systems Corporation
9 Natus Medical Incorporated
10 ECTRON